Literature DB >> 2691514

Two distinct cell lines derived from a human osteosarcoma.

A Kawai1, T Ozaki, S Ikeda, T Oda, M Miyazaki, J Sato, K Taketa, H Inoue.   

Abstract

Two cell lines were established from a human osteosarcoma transplanted into athymic nude mice after the second (O9N2) and fifth passages (HuO9). Both cell lines expressed 1,25(OH)2D3-responsive alkaline phosphatase activity and produced tumors in the dorsum of nude mice that were histologically similar to the original tumor. However, the morphological and growth characteristics of the two cell lines differed. O9N2 cells were large and polygonal, whereas HuO9 cells showed spindle shapes. HuO9 cells had a higher growth rate and saturation density than O9N2 cells. The c-myc oncogene was amplified 4- to 8-fold in HuO9 cells but not in O9N2 cells. Both cell lines had a homozygous internal deletion, lacking the 7.4-kb HindIII fragment in the Rb gene. The results suggest the importance of the c-myc oncogene in the growth and morphological control of human osteosarcoma cells and of the Rb gene in the pathogenesis of the tumor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2691514     DOI: 10.1007/bf00391353

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  18 in total

1.  The quantitative histochemistry of brain. II. Enzyme measurements.

Authors:  O H LOWRY; N R ROBERTS; M L WU; W S HIXON; E J CRAWFORD
Journal:  J Biol Chem       Date:  1954-03       Impact factor: 5.157

2.  Detection of c-sis transcripts and synthesis of PDGF-like proteins by human osteosarcoma cells.

Authors:  D T Graves; A J Owen; R K Barth; P Tempst; A Winoto; L Fors; L E Hood; H N Antoniades
Journal:  Science       Date:  1984-11-23       Impact factor: 47.728

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer.

Authors:  K Saksela; J Bergh; V P Lehto; K Nilsson; K Alitalo
Journal:  Cancer Res       Date:  1985-04       Impact factor: 12.701

5.  Expression of c-myc changes during differentiation of mouse erythroleukaemia cells.

Authors:  H M Lachman; A I Skoultchi
Journal:  Nature       Date:  1984 Aug 16-22       Impact factor: 49.962

6.  c-myc amplification and expression in newly established human osteosarcoma cell lines.

Authors:  E Bogenmann; H Moghadam; Y A DeClerck; A Mock
Journal:  Cancer Res       Date:  1987-07-15       Impact factor: 12.701

7.  Human retinoblastoma susceptibility gene: cloning, identification, and sequence.

Authors:  W H Lee; R Bookstein; F Hong; L J Young; J Y Shew; E Y Lee
Journal:  Science       Date:  1987-03-13       Impact factor: 47.728

8.  Immune elimination of host fibroblasts for the cultivation of human tumors transplanted into nude mice.

Authors:  T Okabe; A Suzuki; N Ohsawa; K Kosaka; T Terasima
Journal:  Cancer Res       Date:  1979-10       Impact factor: 12.701

9.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

10.  Amplification of both c-myc and c-raf-1 oncogenes in a human osteosarcoma.

Authors:  S Ikeda; H Sumii; K Akiyama; S Watanabe; S Ito; H Inoue; H Takechi; G Tanabe; T Oda
Journal:  Jpn J Cancer Res       Date:  1989-01
View more
  9 in total

1.  Establishment of an osteogenic cell line derived from adult mouse bone marrow stroma by use of a recombinant retrovirus.

Authors:  E Mathieu; G Schoeters; F vander Plaetse; J Merregaert
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

2.  Establishment of human osteosarcoma cell lines with high metastatic potential to lungs and their utilities for therapeutic studies on metastatic osteosarcoma.

Authors:  Kenji Kimura; Tetsuhiro Nakano; Yong-Bum Park; Masachika Tani; Hiroyuki Tsuda; Yasuo Beppu; Hideshige Moriya; Jun Yokota
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 3.  "True bone" in vitro?

Authors:  A Schulz
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  S100A7 promotes the migration and invasion of osteosarcoma cells via the receptor for advanced glycation end products.

Authors:  Ken Kataoka; Tomoyuki Ono; Hitoshi Murata; Mika Morishita; Ken-Ichi Yamamoto; Masakiyo Sakaguchi; Nam-Ho Huh
Journal:  Oncol Lett       Date:  2012-02-20       Impact factor: 2.967

Review 5.  Canine and murine models of osteosarcoma.

Authors:  Jessica Beck; Ling Ren; Shan Huang; Erika Berger; Kathleen Bardales; Joshua Mannheimer; Christina Mazcko; Amy LeBlanc
Journal:  Vet Pathol       Date:  2022-03-26       Impact factor: 3.157

6.  Biological properties and gene expression associated with metastatic potential of human osteosarcoma.

Authors:  Tetsuhiro Nakano; Masachika Tani; Yasunori Ishibashi; Kenji Kimura; Yong-Bum Park; Natsuko Imaizumi; Hiroyuki Tsuda; Kazuhiko Aoyagi; Hiroki Sasaki; Susumu Ohwada; Jun Yokota
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

7.  Amplification of the MYC Gene in Osteosarcoma Secondary to Paget's Disease of Bone.

Authors:  T Ueda; J H Healey; A G Huvos; M Ladanyi
Journal:  Sarcoma       Date:  1997

8.  Using a combination of gangliosides and cell surface vimentin as surface biomarkers for isolating osteosarcoma cells in microfluidic devices.

Authors:  Henrietta O Fasanya; Pablo J Dopico; Zachary Yeager; Z Hugh Fan; Dietmar W Siemann
Journal:  J Bone Oncol       Date:  2021-03-24       Impact factor: 4.491

9.  Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.

Authors:  Ling Ren; Arnulfo Mendoza; Jack Zhu; Joseph W Briggs; Charles Halsey; Ellen S Hong; Sandra S Burkett; James Morrow; Michael M Lizardo; Tanasa Osborne; Samuel Q Li; Hue H Luu; Paul Meltzer; Chand Khanna
Journal:  Oncotarget       Date:  2015-10-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.